| scholarly article | Q13442814 |
| P50 | author | Hirokazu Hirai | Q47504115 |
| Ayumu Konno | Q50091363 | ||
| Hanna Goenawan | Q85049431 | ||
| Fathul Huda | Q85222054 | ||
| P2093 | author name string | Yasunori Matsuzaki | |
| Koichi Miyake | |||
| Takashi Shimada | |||
| P2860 | cites work | Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease | Q24644950 |
| miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis | Q24647507 | ||
| A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein | Q24683907 | ||
| Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia. | Q30481610 | ||
| Expansive Gene Transfer in the Rat CNS Rapidly Produces Amyotrophic Lateral Sclerosis Relevant Sequelae When TDP-43 is Overexpressed | Q30497589 | ||
| Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders | Q34205620 | ||
| Brain pathology of spinocerebellar ataxias | Q34298978 | ||
| Self-complementary AAV vectors; advances and applications | Q34804660 | ||
| Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. | Q35025591 | ||
| Patterned Purkinje cell death in the cerebellum | Q35563957 | ||
| Imaging polyglutamine deposits in brain tissue | Q36626097 | ||
| Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice | Q37131550 | ||
| Basic research on cerebellar gene therapy using lentiviral vectors | Q37961590 | ||
| Serotype-independent method of recombinant adeno-associated virus (AAV) vector production and purification | Q38071890 | ||
| Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease | Q39995612 | ||
| Long-term adeno-associated viral vector-mediated expression of truncated TrkB in the adult rat facial nucleus results in motor neuron degeneration. | Q40321814 | ||
| Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration. | Q40329109 | ||
| Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. | Q40644113 | ||
| Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy | Q40924169 | ||
| Selective damage to the cerebellar vermis in chronic alcoholism: a contribution from neurotoxicology to an old problem of selective vulnerability | Q41639728 | ||
| Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters | Q42199204 | ||
| Generation of a neurodegenerative disease mouse model using lentiviral vectors carrying an enhanced synapsin I promoter. | Q42247655 | ||
| Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells. | Q42275945 | ||
| Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC. | Q42502571 | ||
| Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes | Q42739394 | ||
| Crossing the rubicon | Q43103907 | ||
| RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. | Q44964949 | ||
| CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. | Q45298680 | ||
| Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors | Q45417215 | ||
| In vivo transduction of murine cerebellar Purkinje cells by HIV-derived lentiviral vectors | Q45856519 | ||
| Modulation of lentiviral vector tropism in cerebellar Purkinje cells in vivo by a lysosomal cysteine protease cathepsin K. | Q48334396 | ||
| The neonatal blood-brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9. | Q48463127 | ||
| Metabotropic glutamate receptors mGluR2 and mGluR5 are expressed in two non-overlapping populations of Golgi cells in the rat cerebellum | Q48853445 | ||
| Morphological and neurochemical differentiation of large granular layer interneurons in the adult rat cerebellum | Q48866588 | ||
| Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. | Q52560509 | ||
| Suppression of calbindin-D28k expression exacerbates SCA1 phenotype in a disease mouse model. | Q54339710 | ||
| Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias | Q57969464 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 14032 | |
| P577 | publication date | 2014-08-06 | |
| P1433 | published in | Molecular Therapy. Methods & Clinical Development | Q27725341 |
| P1476 | title | Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model | |
| P478 | volume | 1 |
| Q27340422 | A CDC42EP4/septin-based perisynaptic glial scaffold facilitates glutamate clearance. |
| Q36269315 | Aberrant Purkinje cell activity is the cause of dystonia in a shRNA-based mouse model of Rapid Onset Dystonia-Parkinsonism |
| Q37393559 | Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B. |
| Q38787435 | Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site |
| Q57022617 | Effects of Neutralizing Antibody Production on AAV-PHP.B-Mediated Transduction of the Mouse Central Nervous System |
| Q50091328 | Elavl3 is essential for the maintenance of Purkinje neuron axons |
| Q51664427 | Fluorescent-based evaluation of chaperone-mediated autophagy and microautophagy activities in cultured cells. |
| Q36179233 | Fusion of Human Fetal Mesenchymal Stem Cells with "Degenerating" Cerebellar Neurons in Spinocerebellar Ataxia Type 1 Model Mice. |
| Q40365796 | Gene therapy for a mouse model of glucose transporter-1 deficiency syndrome. |
| Q40647579 | Gene vector 'magic bullet': targeted expression in the central nervous system after peripheral delivery using the synapsin promoter |
| Q36127335 | In vivo bioluminescence imaging for leptomeningeal dissemination of medulloblastoma in mouse models |
| Q90747770 | Inappropriate Intrusion of an Axonal Mitochondrial Anchor into Dendrites Causes Neurodegeneration |
| Q40705837 | Inflammation-induced reversible switch of the neuron-specific enolase promoter from Purkinje neurons to Bergmann glia |
| Q100737254 | Intra-cisterna magna delivery of an AAV vector with the GLUT1 promoter in a pig recapitulates the physiological expression of SLC2A1 |
| Q41375421 | Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus After Intravenous Injection. |
| Q37481531 | Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9. |
| Q40906363 | Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors. |
| Q36116091 | Viral Vector-Based Dissection of Marmoset GFAP Promoter in Mouse and Marmoset Brains |
| Q40200102 | Viral Vector-Based Evaluation of Regulatory Regions in the Neuron-Specific Enolase (NSE) Promoter in Mouse Cerebellum In Vivo |
Search more.